课题基金 / 基金详情

Gene therapy-for live cirrhosis by multiplicable hepatocyte and antisense of collagenase-mRNA

Gene therapy-for live cirrhosis by multiplicable hepatocyte and antisense of collagenase-mRNA
基因治疗-通过增殖性肝细胞和胶原酶-mRNA反义治疗活肝硬化
批准号:
07671353
负责人:
OHKOHCHI Nobuhiro
金额:
$0.38万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

OHKOHCHI Nobuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
[目的]本研究的目的是通过移植增殖性肝细胞并应用胶原酶基因反义核酸治疗肝硬变。[材料和方法]研究过程如下。1)建立小鼠和大鼠的肝硬变模型,分析肝纤维化的发生机制。B)可增殖的肝细胞杂交瘤是用栓性肝细胞、实质肝细胞和非实质肝细胞组成的杂交瘤。C)将杂交瘤移植到肝硬变小鼠的肝脏内,并将反义的胶原酶mRNA注入肝脏。对再生正常肝脏的条件进行了研究。[结果]用CCl4复制大鼠肝纤维化模型,观察羟丙醇在大鼠肝硬变过程中的变化。并研制了一种新的激光选择性细胞融合装置。利用该装置,我们尝试制作了实质肝细胞和栓塞型肝细胞的杂交瘤,该杂交瘤可以增殖。我们利用仙台病毒和磷脂制备了hVJ脂质体,用于胶原酶-mRNA反义基因的转导,在分析肝纤维化过程中的研究仍在进行中。
英文摘要
[Purpose] The purpose of this study is to establish a therapy for the liver cirrhosis by a transplantation of proliferative hepatocyte and administration of antisense for mRNA of collagenase. [Materials and Methods] Process of the study were as followed. A) Model of liver cirrhosis is made in mouse and rat and mechanism of fibrosis is analyzed. B) Hybridomas of hepatic cells which can proliferate are made with embrional hepatocytes and parenchymal and nonparenchymal hepatocytes. C) The hybridomas are transplanted into the cirrhotic liver and antisense for the collagenese mRNA is also injected the liver. Conditions of regenerating normal liver are studied. [Results] We made liver cirrhosis using CCl_4 and examined hidroxyprolil activity during changing liver cirrhosis in rats. And we developped a new device for selective cell fusion by Laser device. Using this device we tried to make hybridoma of parenchymal hepatocyte and embrional hepatocyte, which can proliferate. We prepared HVJ liposome using Sendai virus and phospholipid for transfection of antisense of collagenase-mRNA.Studies of investigation in analysis of fibrosing process of liver were still remained.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
板垣英雄、大河内信弘、他: "レーザーを用いた新しい選択的細胞融合法の開発" 薬理と臨床. 6. 1535-1538 (1996)
Hideo Itagaki、Nobuhiro Okochi 等人:“使用激光开发新的选择性细胞融合方法”药理学和临床研究 6. 1535-1538 (1996)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Itagaki H.,et al: "Selective selection method by Laser de vice" Acta Histochemica et Cytochemica. vol29sup. 750-751 (1996)
Itagaki H.等人:“激光装置的选择性选择方法”Acta Histochemica et Cytochemica。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
板垣英雄、他: "レーザーを用いた新しい選択的細胞融合法の開発" 薬理と臨床. vol6,8. 1535-1538 (1996)
Hideo Itagaki 等人:“使用激光开发新的选择性细胞融合方法”,药理学和临床研究,第 6 卷,1535-1538(1996 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Establishment of new treatment by thrombopoietin receptor agonist for liver regeneration in liver cirrhosis and for prevention of liver carcinogenes
    • 批准号:
      26293296
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.4万
    • 财政年份:
      2014
    • 负责人:
      OHKOHCHI Nobuhiro
    • 依托单位:
    New method of differential diagonosis and tailor- made treatmentfor hepatocellular carcinoma by antisense RNA
    • 批准号:
      23650611
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      OHKOHCHI Nobuhiro
    • 依托单位:
    Translational research of developing liver regeneration and antie agent derived from platelets
    • 批准号:
      20390350
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.73万
    • 财政年份:
      2008
    • 负责人:
      OHKOHCHI Nobuhiro
    • 依托单位:
    Development of new treatment for severe liver diseases using platelets
    • 批准号:
      17390359
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.22万
    • 财政年份:
      2005
    • 负责人:
      OHKOHCHI Nobuhiro
    • 依托单位:
    海外基金